A Study to Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Oral Venetoclax Tablets in Combination With Subcutaneously (SC) or Intravenously (IV) Injected Azacitidine in Colombia

NCT05587049 · clinicaltrials.gov ↗

RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Sponsor

AbbVie